Respiratory pathogen spectrum, peripheral blood immunophenotype, and clinical characteristics of hospitalized children with Kawasaki disease complicated by acute respiratory tract infection: a retrospective cohort study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Objective To systematically delineate the respiratory microbiological landscape, peripheral immunophenotypic dynamics, and clinical trajectories in hospitalized children with Kawasaki disease (KD) complicated by acute respiratory tract infection (ARTI), and to evaluate accessible creatine kinase (CK)-normalized ratio models for early differential diagnosis. Methods This retrospective study analyzed a discovery cohort of 139 ARTI-complicated KD cases and 600 uncomplicated ARTI controls using targeted next-generation sequencing (tNGS) and flow cytometry. Novel CK-normalized ratio models were developed and evaluated in an independent validation cohort (156 KD and 203 controls). Results High respiratory pathogen co-detection was observed in hospitalized children across both cohorts (85.6% in KD vs. 85.3% in ARTI controls). Multivariate and specimen-stratified analyses revealed that human adenovirus (HAdV) was selectively enriched in the lower respiratory tract (BALF: adjusted OR = 3.321, 95% CI: 1.324–8.331, P = 0.011). KD patients exhibited marked peripheral lymphocyte depletion (ALC: 2.82 vs. 3.68 × 10 9 /L, P < 0.001), CD4 + T-cell reduction, and a proportional increase in CD19 + B cells (all P < 0.05). Leveraging paradoxical CK suppression during hyper-inflammation, CK-normalized ratio models consistently yielded higher numerical AUCs compared to solitary biomarkers; in the independent validation cohort, PCT/CK achieved AUCs of 0.870 (95% CI: 0.832–0.909) for total KD and 0.897 (95% CI: 0.860–0.935) for complete KD (cKD), while CRP/CK achieved an AUC of 0.835 (95% CI: 0.770–0.900, specificity = 90.64%) for incomplete KD (iKD). Clinically, KD patients had a lower overall respiratory complication rate (36.7% vs. 47.2%) but marked extrapulmonary burdens, including liver injury (19.4% vs. 3.7%), and coronary artery lesions (26.6%, with coronary artery aneurysms [Z ≥ 2.5] in 20.1%), resulting in longer stays and higher healthcare costs (all P < 0.05). Conclusion ARTI-complicated KD involves a distinct immunopathological process potentially associated with deep lower respiratory HAdV infection. The independently validated PCT/CK and CRP/CK models offer accessible, cost-effective adjunctive tools to assist in the in-hospital differential diagnosis of ARTI-complicated KD. Clinical management requires multidisciplinary balancing of intensive anti-inflammatory therapy with infection control.
Source: Frontiers in Immunology
Authors: Chunyun Fu(Conceptualization, Data curation, Funding acquisition, Writing – original draft), Xiaoying Chen(Data curation, Formal analysis, Visualization, Writing – original draft), Yushan Zhang(Data curation, Formal analysis, Visualization, Writing – original draft), Lishai Mo(Data curation, Formal analysis, Writing – original draft), Junming Lu(Data curation, Formal analysis, Writing – original draft), Liuyan Chen(Data curation, Formal analysis, Writing – original draft), Jiangyang Zhao(Data curation, Formal analysis, Writing – original draft), Xuehua Hu(Investigation, Resources, Writing – original draft), Yanmei Li(Investigation, Resources, Writing – original draft), Cuihong Lu(Investigation, Resources, Writing – original draft), Yong Han(Conceptualization, Formal analysis, Validation, Writing – review & editing), Jie Tan(Data curation, Investigation, Resources, Writing – review & editing), Shaoling Wei(Data curation, Investigation, Resources, Validation, Writing – review & editing)
Institution: Guangxi Maternal and Child Health Hospital
Language: English
Field: Medicine
Domain: Health Sciences
Keywords: Kawasaki disease, acute respiratory infections, respiratory pathogens, human adenovirus, lymphocyte depletion, creatine kinase, procalcitonin, C-reactive protein, differential diagnosis, coronary artery lesions, liver injury, hospitalized children, targeted next-generation sequencing, bronchoalveolar lavage, biomarkers, hyperinflammation
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236405370
